EYPT
EyePoint Pharmaceuticals (EYPT)
$91
About EyePoint Pharmaceuticals (EYPT)
EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Details
Daily high
$13.94
Daily low
$13.03
Price at open
$13.04
52 Week High
$19.11
52 Week Low
$9.65
Market cap
1.1B
Dividend yield
0.00%
Volume
1.1M
Avg. volume
1.6M
P/E ratio
-3.43
EyePoint Pharmaceuticals News
Details
Daily high
$13.94
Daily low
$13.03
Price at open
$13.04
52 Week High
$19.11
52 Week Low
$9.65
Market cap
1.1B
Dividend yield
0.00%
Volume
1.1M
Avg. volume
1.6M
P/E ratio
-3.43